GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more zbecker Fri, 11/08/2024 - 15:27

AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study kdunleavy Fri, 11/08/2024 - 15:08

Daiichi Sankyo links up with Korea's Alteogen on subcutaneous Enhertu in $300M licensing deal zbecker Fri, 11/08/2024 - 11:00

Investment fund Oaktree calls for board shakeup at Indivior, accusing company of 'value destruction' fkansteiner Fri, 11/08/2024 - 10:20

FDA proposes ban on main ingredient in many OTC decongestants kdunleavy Fri, 11/08/2024 - 10:03

J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing aliu Fri, 11/08/2024 - 09:40